Steve Aselage, Director at Travere Therapeutics, Inc. (TVTX), sold 18,782 shares at $23.43 ($370K) on 2020-12-02, disclosed to the SEC on 2020-12-04.
Open-market sale of $370k TVTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,000 | $0 | 0.0% |
| 2 | $23.43 | 7,891 | $185K | 50.0% |
| 3 | $23.43 | 7,891 | $185K | 50.0% |
| Total | $19.69 avg | 18,782 | $370K | 100% |
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |